MedTrace Logo

Treating Social Cognition With Theta Burst Stimulation: a Multicentric Study

NCT02479919 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2022-03-09

No results posted yet for this study

Summary

The purpose of the study is to test a new treatment of social cognition deficits in patients with schizophrenia or schizoaffective disorder by transcranial magnetic stimulation (theta-burst). The study will also identify clinical, psychomotor and cognitive variables that are the most sensitive to treatment, and estimate the most sensitive treatment target between patients.

Conditions

  • Social Cognition in Patients With Schizophrenia

Interventions

DEVICE

Magstim® Active TBS

Non-invasive transcranial magnetic stimulation inducing changes in cortical excitability depending on the cortical target (except for sham stimulation)

DEVICE

Magstim® Sham TBS

Sham stimulation

Sponsors & Collaborators

  • University Hospital, Rouen

    collaborator OTHER

  • Centre Hospitalier Universitaire Dijon

    collaborator OTHER

  • Poitiers University Hospital

    collaborator OTHER

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Sonia Dollfus, Pr · University Hospital, Caen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-11
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02479919 on ClinicalTrials.gov